Thursday 21 August 2014
 
»
Tag
 
»
biotech

GSK extends $2.6bn offer to key partner

GlaxoSmithKline has extended its $2.6 billion offer to buy long-time partner Human Genome Sciences until the end of June as it battles the US biotech company's reluctant management. The price remains unchanged at $13 a share under the 

More…

$1-5bn seen optimal for biotech M&A

Biotech deals in the $1 billion to $5 billion range are likely to be a sweet spot for drug companies looking to bolster their pipelines through M&A in an increasingly tough environment, Ernst & Young said. Big pharma companies are

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads